nprnews_____ = ||| lubuntu at wor2 1TXN|||U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||The Food and Drug Administration gave emergency authorization to Ellume’s rapid test in December, after it showed 96% accuracy in a U.S. clinical study.


U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

Ellume Limited, an Australian company, manufactures a 15-minute at-home test for the coronavirus which causes COVID-19.

Ellume Limited


hide caption

toggle caption

Ellume Limited


Coronavirus Updates


U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests



The Food and Drug Administration gave emergency authorization to Ellume’s rapid test in December, after it showed 96% accuracy in a U.S. clinical study.


Leave a comment

Design a site like this with WordPress.com
Get started